SCHEMBL4432949

SCHEMBL4432949

O=CCc1cc2cccc(F)c2nc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 1/20 0.40
DRD3 P35462 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ALDH1A1 P00352 3/20 0.37
NPSR1 Q6W5P4 2/20 0.37
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
KMT2A Q03164 4/20 0.35
KDR P35968 3/20 0.32
FAAH O00519 1/20 0.32
PFKFB3 Q16875 1/20 0.32
MEN1 O00255 2/20 0.31
MAPK1 P28482 2/20 0.31
MAPT P10636 2/20 0.31
HTT P42858 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14047371 0.83 DRD4 (0.43) DRD4DRD3L3MBTL1ALDH1A1NPSR1
SCHEMBL2719332 0.82 MEN1 (0.44) DRD4DRD3L3MBTL1ALDH1A1NPSR1
SCHEMBL3656611 0.82 DRD4 (0.59) DRD4DRD3L3MBTL1ALDH1A1NPSR1
SCHEMBL247016 0.77 DRD4 (0.38) DRD4DRD3L3MBTL1ALDH1A1NPSR1
SCHEMBL19331490 0.77 ALDH1A1 (0.40) DRD4DRD3L3MBTL1ALDH1A1NPSR1
SCHEMBL19331488 0.76 ALDH1A1 (0.44) ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL23747875 0.75 MPO (0.40) DRD4DRD3L3MBTL1ALDH1A1NPSR1
SCHEMBL15321070 0.71 KMT2A (0.43) L3MBTL1ALDH1A1NPSR1CYP1A2CYP3A4
SCHEMBL12970079 0.70 MBNL1 (0.40) DRD4DRD3L3MBTL1ALDH1A1NPSR1
SCHEMBL15994927 0.70 CYP1A2 (0.38) L3MBTL1ALDH1A1CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2834231-A1 HETEROCYCLIC COMPOUNDS AND THEIR USES Amgen Inc. (US) 2015-02-11 EP disclosed
WO-2013152150-A1 HETEROCYCLIC COMPOUNDS AND THEIR USES AMGEN INC. (US) 2013-10-10 WO disclosed
EP-2137186-A1 HETEROCYCLIC COMPOUNDS AND THEIR USES Amgen Inc. (US) 2009-12-30 EP disclosed
WO-2008118468-A1 HETEROCYCLIC COMPOUNDS AND THEIR USES AMGEN INC. (US) 2008-10-02 WO disclosed